Published January 27, 2015
| Version v1
Journal article
Open
Identification and Functional Characterization of G6PC2 Coding Variants Influencing Glycemic Traits Define an Effector Transcript at the G6PC2-ABCB11 Locus
Creators
- Mahajan, Anubha1
- Sim, Xueling2
- Ng, Hui Jin1
- Manning, Alisa3
- Rivas, Manuel A.1
- Highland, Heather M.4
- Locke, Adam E.2
- Garup, Niels5
- Im, Hae Kyung6
- Cingolani, Pablo7
- Flannick, Jason8
- Fontanillas, Pierre3
- Fuchsberger, Christian2
- Gaulton, Kyle J.1
- Teslovich, Tanya M.2
- Rayner, N. William1
- Robertson, Neil R.1
- Beer, Nicola L.1
- Rundle, Jana K.1
- Bork-Jensen, Jette5
- Ladenvall, Claes9
- Blancher, Christine1
- Buck, David1
- Buck, Gemma1
- Burtt, Noël P.3
- Gabriel, Stacey3
- Gjesing, Anette P.5
- Groves, Christopher J.1
- Hollensted, Mette5
- Huyghe, Jeroen R.2
- Jackson, Anne U.2
- Jun, Goo2
- Justesen, Johanne Marie5
- Mangino, Massimo10
- Murphy, Jacquelyn3
- Neville, Matt1
- Onofrio, Robert3
- Small, Kerrin S.10
- Stringham, Heather M.2
- Syvänen, Ann-Christine11
- Trakalo, Joseph1
- Abecasis, Goncalo2
- Bell, Graeme I.6
- Blangero, John12
- Cox, Nancy J.6
- 1. University of Oxford
- 2. University of Michigan
- 3. Broad Institute
- 4. University of Texas Health Science Center at Houston
- 5. University of Copenhagen
- 6. University of Chicago
- 7. McGill University
- 8. Massachusetts General Hospital
- 9. Lund University
- 10. King's College London
- 11. Uppsala University
- 12. Texas Biomedical Research Institute
Description
Genome wide association studies (GWAS) for fasting glucose (FG) and insulin (FI) have identified common variant signals which explain 4.8% and 1.2% of trait variance, respectively. It is hypothesized that low-frequency and rare variants could contribute substantially to unexplained genetic variance. To test this, we analyzed exome-array data from up to 33,231 non-diabetic individuals of European ancestry. We found exome-wide significant (P<5×10-7) evidence for two loci not previously highlighted by common variant GWAS: GLP1R (p.Ala316Thr, minor allele frequency (MAF)=1.5%) influencing FG levels, and URB2 (p.Glu594Val, MAF = 0.1%) influencing FI levels. Coding variant associations can highlight potential effector genes at (non-coding) GWAS signals. At the G6PC2/ABCB11 locus, we identified multiple coding variants in G6PC2 (p.Val219Leu, p.His177Tyr, and p.Tyr207Ser) influencing FG levels, conditionally independent of each other and the non-coding GWAS signal. In vitro assays demonstrate that these associated coding alleles result in reduced protein abundance via proteasomal degradation, establishing G6PC2 as an effector gene at this locus. Reconciliation of single-variant associations and functional effects was only possible when haplotype phase was considered. In contrast to earlier reports suggesting that, paradoxically, glucose-raising alleles at this locus are protective against type 2 diabetes (T2D), the p.Val219Leu G6PC2 variant displayed a modest but directionally consistent association with T2D risk. Coding variant associations for glycemic traits in GWAS signals highlight PCSK1, RREB1, and ZHX3 as likely effector transcripts. These coding variant association signals do not have a major impact on the trait variance explained, but they do provide valuable biological insights.
Notes
Data availability
This is a meta-analysis that was conducted on summary level results. Individual level data was not shared amongst the authors of the manuscript, and the corresponding authors are not in a position to make the individual level data available. For most of the samples included, individual level data deposition is precluded by existing consents, and other issues related to individual privacy. Summary level data from the meta-analysis are available from the DIAGRAM (http://www.diagram-consortium.org/Mahajan_2014_ExomeChip/) and LocusZoom (http://csg.sph.umich.edu/locuszoom/) website.
Files
journal.pgen.1004876.pdf
Files
(4.8 MB)
| Name | Size | Download all |
|---|---|---|
|
Article md5:624aad64f050660607b412f4db37377b |
3.9 MB | Preview Download |
|
md5:87a0d42489d948aa028a274e8edc431b
|
869.1 kB | Preview Download |
Additional details
Identifiers
- DOI
- 10.1371/journal.pgen.1004876
- Other
- oai:uchicago.tind.io:10885
Funding
- Agency for Science, Technology and Research
- FWF Austrian Science Fund
- J-3401
- Massachusetts General Hospital
- Research Scholars Award
- Wellcome Trust
- Senior Research Fellowship in Basic and Biomedical Science
- National Institute of Diabetes and Digestive and Kidney Diseases
- R01 DK078616
- National Institute of Diabetes and Digestive and Kidney Diseases
- K24 DK080140
- Wellcome Trust
- WT098381
- National Institutes of Health
- Wellcome Trust
- Research Career Development Fellowship
- Wellcome Trust
- Senior Research Fellowship in Basic and Biomedical Science
- National Institutes of Health
- DK085526
- National Institutes of Health
- DK085501
- National Institutes of Health
- DK085524
- National Institutes of Health
- DK085545
- National Institutes of Health
- DK085584
- National Institutes of Health
- DK088389
- Wellcome Trust
- 090367
- Wellcome Trust
- 098381
- Wellcome Trust
- 090532
- Wellcome Trust
- 083948
- Wellcome Trust
- 085475
- Medical Research Council
- G0601261
- European Union
- Framework 7
- National Institute of Diabetes and Digestive and Kidney Diseases
- DK098032
- Oxford Biomedical Research
- Wellcome Trust
- WT098017
- Wellcome Trust
- WT064890
- Wellcome Trust
- WT090532
- Uppsala University
- Uppsala University Hospital
- Swedish Research Council
- Swedish Heart-Lung Foundation
- Wellcome Trust
- Study Cohort Wellcome Trust Functional Genomics Grant
- Wellcome Trust
- Scottish Health Informatics Programme
- European Commission
- Seventh Framework Programme
- National Institute for Health and Care Research
- European Research Council
- Advanced Principal Investigator award
- Lundbeck Foundation
- Danmarks Frie Forskningsfond
- Novo Nordisk Foundation
- Research Council of Finland
- 124243
- Finnish Foundation for Cardiovascular Research
- Finnish Diabetes Association
- Tekes
- 1510/31/06
- European Commission
- HEALTH-F2-2007-201681
- National Institutes of Health
- DK093757
- National Institutes of Health
- DK072193
- National Institutes of Health
- DK062370
- National Institutes of Health
- 1Z01 HG000024
- National Institutes of Health
- DK093757
- National Institutes of Health
- DK072193
- National Institutes of Health
- DK062370
- National Institutes of Health
- 1Z01 HG000024
- Finnish Foundation for Cardiovascular Research
- Research Council of Finland
- 139635
- Finnish Institute for Health and Welfare
- Finnish Diabetes Association
- Ministry of Social Affairs and Health
- Research Council of Finland
- 129293
- European Commission
- 2004310
- Unknown funder
- Finnish Slot Machine Association
- Research Council of Finland
- 117844
- Research Council of Finland
- 40758
- Research Council of Finland
- 211497
- Research Council of Finland
- 118590
- Ministry of Social Affairs and Health
- 5254
- Tekes
- 40058/07
- NordForsk
- 070014
- Diabetes Tutkimussaatio
- Yrjö Jahnsson Foundation
- 56358
- Sigrid Jusélius Foundation
- Tekes
- 70103/06
- Tekes
- 40058/07
- Ministry of Education and Culture
- 627;2004-2011
- Research Council of Finland
- 102318
- Research Council of Finland
- 123885
- Kuopio University Hospital
- Finnish Heart Association
- Päivikki and Sakari Sohlberg Foundation
- European Commission
- FP6 Integrated Project
- Social Insurance Institution
- LSHM-CT-2004-005272
- City of Kuopio
- Pirkanmaa Hospital District
- Etelä-Pohjanmaan Sairaanhoitopiiri
- Central Finland Health Care District